CBT-1
Term · Oncology and biomedicine · MLC-T-ONC-001509
A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called MDR modulator CBT-1.
| Identifier | MLC-T-ONC-001509 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | MDR modulator CBT-1 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001509",
"term": "CBT-1",
"field": "Oncology and biomedicine",
"definition": "A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called MDR modulator CBT-1.",
"expansions": [
"MDR modulator CBT-1"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cbt-1/"
}
Record 4,350 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.